Novozymes B (NZYMBc)

Featured here, the Income Statement (earnings report) for Novozymes B, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

348.10 -0.70 (-0.20%)

13:14:45 Delayed Data DKK Disclaimer

NZYMBc Income Statement

Total Revenue
Total Operating Expenses
Operating Income

Name	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Total Revenue	4,529	4,367	4,286	3,834	-
Revenue	4,529	4,367	4,286	3,834	-
Other Revenue, Total	0	0	0	0	-
Cost of Revenue, Total	2,093	2,019	1,907	1,670	-
Gross Profit	2,436	2,348	2,379	2,164	-
Total Operating Expenses	3,587	3,080	3,176	3,142	-
Selling/General/Admin. Expenses, Total	778	826	790	903	-
Research & Development	520	475	498	485	-
Depreciation / Amortization	-1,115	377	377	-	-
Interest Expense (Income) - Net Operating	-71	-10	-11	-71	-
Unusual Expense (Income)	-	-	-	-	-
Other Operating Expenses, Total	1,382	-607	-385	155	-
Operating Income	942	1,287	1,110	692	-
Interest Income (Expense), Net Non-Operating	-	-	-	-	-
Gain (Loss) on Sale of Assets	468	122	-	-	-
Other, Net	-571	-101	63	-201	-
Net Income Before Taxes	1,045	1,388	1,047	771	-
Provision for Income Taxes	168	235	230	148	-
Net Income After Taxes	877	1,153	817	623	-
Minority Interest	391	387	394	379	-
Equity In Affiliates	-	-	-	-	-
U.S GAAP Adjustment	-	-	-	-	-
Net Income Before Extraordinary Items	883	1,152	809	625	-
Total Extraordinary Items	0	0	0	0	-
Net Income	883	1,152	809	625	-
Total Adjustments to Net Income	0	0	0	0	-
Income Available to Common Excluding Extraordinary Items	883	1,152	809	625	-
Dilution Adjustment	-0.71	-0.58	-1.26	-1.17	-
Diluted Net Income	883.71	1,152.58	810.26	626.17	-
Diluted Weighted Average Shares	277.94	278.40	279.40	-	-
Diluted EPS Excluding Extraordinary Items	3.18	4.14	2.90	2.24	-
DPS - Common Stock Primary Issue	6	5.50	-	-	-
Diluted Normalized EPS	1.03	3.11	2.31	1.41	-

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.